Eli Lilly, Novo reportedly nearing U.S. deals for obesity drug prices
Weight-loss drugmakers Eli Lilly (LLY) and Novo Nordisk (NVO) (OTCPK:NONOF) are planning to announce new drug pricing deals with the White House, including for their blockbuster obesity therapies, Endpoints News reported on Tuesday, citing sources familiar...
Seeking Alpha